- Filed
- Feb 26, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 20, 2026 | 276.55M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 280M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 281M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 283M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 283M sh |
| Stock Repurchased | Q2 2026 · Jan 31, 2026 | $1.79B |
| Stock Repurchased | Q2 2026 · Jan 31, 2025 | $1.27B |
| Dividends Paid | Q2 2026 · Jan 31, 2026 | $682M |
| Dividends Paid | Q2 2026 · Jan 31, 2025 | $596M |
| Capex | Q2 2026 · Jan 31, 2026 | $84M |
| Capex | Q2 2026 · Jan 31, 2025 | $64M |
| Operating Cash Flow | Q2 2026 · Jan 31, 2026 | $2.21B |
| Operating Cash Flow | Q2 2026 · Jan 31, 2025 | $1.43B |
| Long Term Debt | Q2 2026 · Jan 31, 2026 | $5.41B |
| Long Term Debt | Q2 2026 · Jul 31, 2025 | $5.97B |
| Cash And Equivalents | Q2 2026 · Jan 31, 2026 | $2.94B |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $2.88B |
| Cash And Equivalents | Q2 2026 · Jan 31, 2025 | $2.44B |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | $19.06B |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $19.32B |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $19.71B |
| Stockholders Equity | Q2 2026 · Jan 31, 2025 | $17.95B |
| Stockholders Equity | Q2 2026 · Oct 31, 2024 | $18.14B |
| Stockholders Equity | Q2 2026 · Jul 31, 2024 | $18.44B |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $8.84B |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $10.37B |
| Total Liabilities | Q2 2026 · Jan 31, 2026 | $15.23B |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $17.25B |
| Current Assets | Q2 2026 · Jan 31, 2026 | $11.7B |
| Current Assets | Q2 2026 · Jul 31, 2025 | $14.11B |
| Total Assets | Q2 2026 · Jan 31, 2026 | $34.28B |
| Total Assets | Q2 2026 · Jul 31, 2025 | $36.96B |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $2.48 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $4.06 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $1.67 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $2.36 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $2.49 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $4.09 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $1.68 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $2.38 |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $401M |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $823M |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $389M |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $783M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $836M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $1.68B |
| Rd Expense | Q2 2026 · Jan 31, 2025 | $716M |
| Rd Expense | Q2 2026 · Jan 31, 2025 | $1.42B |
| Net Income | Q2 2026 · Jan 31, 2026 | $693M |
| Net Income | Q2 2026 · Jan 31, 2026 | $1.14B |
| Net Income | Q2 2026 · Jan 31, 2025 | $471M |
| Net Income | Q2 2026 · Jan 31, 2025 | $668M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $855M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $1.39B |
| Operating Income | Q2 2026 · Jan 31, 2025 | $593M |
| Operating Income | Q2 2026 · Jan 31, 2025 | $864M |
| Revenue | Q2 2026 · Jan 31, 2026 | $4.65B |
| Revenue | Q2 2026 · Jan 31, 2026 | $8.54B |
| Revenue | Q2 2026 · Jan 31, 2025 | $3.96B |
| Revenue | Q2 2026 · Jan 31, 2025 | $7.25B |